<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39187577</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>26</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Long COVID diagnostic with differentiation from chronic lyme disease using machine learning and cytokine hubs.</ArticleTitle><Pagination><StartPage>19743</StartPage><MedlinePgn>19743</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">19743</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-70929-y</ELocationID><Abstract><AbstractText>The absence of a long COVID (LC) or post-acute sequelae of COVID-19 (PASC) diagnostic has profound implications for research and potential therapeutics given the lack of specificity with symptom-based identification of LC and the overlap of symptoms with other chronic inflammatory conditions. Here, we report a machine-learning approach to LC/PASC diagnosis on 347 individuals using cytokine hubs that are also capable of differentiating LC from chronic lyme disease (CLD). We derived decision tree, random forest, and gradient-boosting machine (GBM) classifiers and compared their diagnostic capabilities on a dataset partitioned into training (178 individuals) and evaluation (45 individuals) sets. The GBM model generated 89% sensitivity and 96% specificity for LC with no evidence of overfitting. We tested the GBM on an additional random dataset (106 LC/PASC and 18 Lyme), resulting in high sensitivity (97%) and specificity (90%) for LC. We constructed a Lyme Index confirmatory algorithm to discriminate LC and CLD.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Patterson</LastName><ForeName>Bruce K</ForeName><Initials>BK</Initials><AffiliationInfo><Affiliation>IncellDx Inc, 30920 Huntwood Ave, San Carlos, Hayward, CA, 94544, USA. brucep@incelldx.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guevara-Coto</LastName><ForeName>Jose</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>IncellDx Inc, 30920 Huntwood Ave, San Carlos, Hayward, CA, 94544, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mora</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Lab of Tumor Chemosensitivity, Faculty of Microbiology, CIET/CICICA, Universidad de Costa Rica, San Jos&#xe9;, Costa Rica.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Francisco</LastName><ForeName>Edgar B</ForeName><Initials>EB</Initials><AffiliationInfo><Affiliation>IncellDx Inc, 30920 Huntwood Ave, San Carlos, Hayward, CA, 94544, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yogendra</LastName><ForeName>Ram</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Lawrence General Hospital, Lawrence, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mora-Rodr&#xed;guez</LastName><ForeName>Rodrigo A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Lab of Tumor Chemosensitivity, Faculty of Microbiology, CIET/CICICA, Universidad de Costa Rica, San Jos&#xe9;, Costa Rica.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beaty</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>IncellDx Inc, 30920 Huntwood Ave, San Carlos, Hayward, CA, 94544, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemaster</LastName><ForeName>Gwyneth</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>IncellDx Inc, 30920 Huntwood Ave, San Carlos, Hayward, CA, 94544, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaplan DO</LastName><ForeName>Gary</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Community and Family Medicine, Georgetown University School of Medicine, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katz</LastName><ForeName>Amiram</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurology Specialist Affiliated With Norwalk Hospital, Orange, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellanti</LastName><ForeName>Joseph A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Departments of Pediatrics and Microbiology-Immunology, and the International Center for Interdisciplinary Studies of Immunology, Georgetown University Medical Center, Washington, DC, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008193" MajorTopicYN="Y">Lyme Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="Y">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077342" MajorTopicYN="N">Post-Lyme Disease Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Chronic lyme disease (CLD)</Keyword><Keyword MajorTopicYN="N">Cytokines</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Machine Learning/AI</Keyword><Keyword MajorTopicYN="N">Myalgic encephalomyelitis-chronic fatigue syndrome (ME-CFS)</Keyword><Keyword MajorTopicYN="N">PASC</Keyword></KeywordList><CoiStatement>B.K.P, C.B., J.G, and E.B.F. are employees of IncellDx, Inc.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>27</Day><Hour>9</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>27</Day><Hour>9</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>26</Day><Hour>23</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39187577</ArticleId><ArticleId IdType="pmc">PMC11347643</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-70929-y</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-70929-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schett, G., McInnes, I. B. &amp; Neurath, M. F. Reframing immune-mediated inflammatory diseases through signature cytokine hubs. N. Engl. J. Med.385, 628&#x2013;639 (2021). 10.1056/NEJMra1909094</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1909094</ArticleId><ArticleId IdType="pubmed">34379924</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson, B. K. et al. Immune-based prediction of COVID-19 severity and chronicity decoded using machine learning. Front. Immunol.12, 700782. 10.3389/fimm.u (2021). 10.3389/fimm.u</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimm.u</ArticleId><ArticleId IdType="pmc">PMC8273732</ArticleId><ArticleId IdType="pubmed">34262570</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis, H. E. et al. Characterizing LC in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine38, 101019. 10.1016/j.eclinm (2021). 10.1016/j.eclinm</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai, T. et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA329, 1934&#x2013;1946. 10.1001/jama.2023.8823 (2023). 10.1001/jama.2023.8823</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong, K. H., Shapiro, E. D. &amp; Soffer, G. K. A review of post-treatment CLD disease syndrome and chronic CLD disease for the practicing immunologist. Clin. Rev. Allergy Immunol.62, 264&#x2013;271. 10.1007/s12016-021-08906-w (2022). 10.1007/s12016-021-08906-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-021-08906-w</ArticleId><ArticleId IdType="pubmed">34687445</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman, L. et al. Myalgic encephalomyelitis/chronic fatigue syndrome: Essentials of diagnosis and management. Mayo Clin. Proc.96, 2861&#x2013;2878. 10.1016/j.mayocp.2021.07.004 (2021). 10.1016/j.mayocp.2021.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.07.004</ArticleId><ArticleId IdType="pubmed">34454716</ArticleId></ArticleIdList></Reference><Reference><Citation>Branda, J. A. &amp; Steere, A. C. Laboratory diagnosis of CLD Borreliosis. Clin. Microbiol. Rev.34, e00018-19. 10.1128/CMR.00018-19 (2021). 10.1128/CMR.00018-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00018-19</ArticleId><ArticleId IdType="pmc">PMC7849240</ArticleId><ArticleId IdType="pubmed">33504503</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao, Y. et al. Machine learning based early warning system enables accurate mortality risk prediction for COVID-19. Nat. Commun.11, 5033. 10.1038/s41467-020-18684-2 (2020). 10.1038/s41467-020-18684-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18684-2</ArticleId><ArticleId IdType="pmc">PMC7538910</ArticleId><ArticleId IdType="pubmed">33024092</ArticleId></ArticleIdList></Reference><Reference><Citation>Bousquet, A. et al. Deep learning forecasting using time-varying parameters of the SIRD model for COVID-19. Sci. Rep.12, 3030. 10.1038/s41598-022-06992-0 (2022). 10.1038/s41598-022-06992-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-06992-0</ArticleId><ArticleId IdType="pmc">PMC8863886</ArticleId><ArticleId IdType="pubmed">35194090</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki, A. et al. Computer-aided diagnosis of chest X-ray for COVID-19 diagnosis in external validation study by radiologists with and without deep learning system. Sci. Rep.13, 17533. 10.1038/s41598-023-44818-9 (2023). 10.1038/s41598-023-44818-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-44818-9</ArticleId><ArticleId IdType="pmc">PMC10579343</ArticleId><ArticleId IdType="pubmed">37845348</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, L., Lin, Z. Q. &amp; Wong, A. COVID-Net: a tailored deep convolutional neural network design for detection of COVID-19 cases from chest X-ray images. Sci. Rep.10, 19549. 10.1038/s41598-020-76550-z (2020). 10.1038/s41598-020-76550-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-76550-z</ArticleId><ArticleId IdType="pmc">PMC7658227</ArticleId><ArticleId IdType="pubmed">33177550</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishio, M. et al. Deep learning model for the automatic classification of COVID-19 pneumonia, non-COVID-19 pneumonia, and the healthy: A multi-center retrospective study. Sci. Rep.12, 8214. 10.1038/s41598-022-11990-3 (2022). 10.1038/s41598-022-11990-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-11990-3</ArticleId><ArticleId IdType="pmc">PMC9113076</ArticleId><ArticleId IdType="pubmed">35581272</ArticleId></ArticleIdList></Reference><Reference><Citation>Shor, S. et al. CLD Disease: An evidence-based definition by the ILADS Working Group. Antibiotics8, 269. 10.3390/antibiotics80402691 (2019). 10.3390/antibiotics80402691</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics80402691</ArticleId><ArticleId IdType="pmc">PMC6963229</ArticleId><ArticleId IdType="pubmed">31888310</ArticleId></ArticleIdList></Reference><Reference><Citation>Mckinney W. Pandas: a Foundational Python Library for Data Analysis and Statistics. http://pandas.sf.net [Accessed April 17, 2021]</Citation></Reference><Reference><Citation>Van Rossum G. Python programming language. in USENIX annual technical conference, 1&#x2013;36.</Citation></Reference><Reference><Citation>Srinath KR. Python-The fastest growing programming language. Int Res J Eng Technol (2017) www.irjet.net [Accessed June 15, 2023].</Citation></Reference><Reference><Citation>Kramer, O. Scikit-learn. Stud. Big Data20, 45&#x2013;53. 10.1007/978-3-319-33383-05 (2016).10.1007/978-3-319-33383-05</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-33383-05</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonara, S., Ristow, L., McCarthy, J. &amp; Coburn, J. Effect of Borrelia burgdorferi OspC at the site of inoculation in mouse skin. Infect. Immun.78, 4723. 10.1128/IAI.00464-10 (2010). 10.1128/IAI.00464-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.00464-10</ArticleId><ArticleId IdType="pmc">PMC2976318</ArticleId><ArticleId IdType="pubmed">20696825</ArticleId></ArticleIdList></Reference><Reference><Citation>Rha, M. S. &amp; Shin, E. C. Activation or exhaustion of CD8+&#xa0;T cells in patients with COVID-19. Cell. Mol. Immunol.18, 2325&#x2013;2333. 10.1038/s41423-021-00750-4 (2021). 10.1038/s41423-021-00750-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-021-00750-4</ArticleId><ArticleId IdType="pmc">PMC8374113</ArticleId><ArticleId IdType="pubmed">34413488</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson, B. K. et al. CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14. Int. J. Infect. Dis.103, 25&#x2013;32. 10.1016/j.ijid.2020.10.101 (2021). 10.1016/j.ijid.2020.10.101</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.10.101</ArticleId><ArticleId IdType="pmc">PMC7654230</ArticleId><ArticleId IdType="pubmed">33186704</ArticleId></ArticleIdList></Reference><Reference><Citation>Song, J. W. et al. Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nat. Commun.8, 3410. 10.1038/s41467-020-17240-2 (2020).10.1038/s41467-020-17240-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17240-2</ArticleId><ArticleId IdType="pmc">PMC7343781</ArticleId><ArticleId IdType="pubmed">32641700</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner, J. S. et al. SARS-CoV-2 Viral RNA shedding for more than 87 days in an individual with an impaired CD8+ T cell response. Front. Immunol.8, 618402. 10.3389/fimmu.2020.618402 (2021).10.3389/fimmu.2020.618402</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.618402</ArticleId><ArticleId IdType="pmc">PMC7820941</ArticleId><ArticleId IdType="pubmed">33488630</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Castro, A. C. et al. Difference in mortality rates in hospitalized COVID-19 patients identified by cytokine profile clustering using a machine learning approach: An outcome prediction alternative. Front. Med.9, 987182. 10.3389/fmed.2022.987182 (2022).10.3389/fmed.2022.987182</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.987182</ArticleId><ArticleId IdType="pmc">PMC9530472</ArticleId><ArticleId IdType="pubmed">36203752</ArticleId></ArticleIdList></Reference><Reference><Citation>Batheja, S., Nields, J. A., Landa, A. &amp; Fallon, B. A. Post-treatment CLD syndrome and central sensitization. J. Neuropsychiatry Clin. Neurosci.25, 176&#x2013;186. 10.1176/appi.neuropsych.12090223 (2013). 10.1176/appi.neuropsych.12090223</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.neuropsych.12090223</ArticleId><ArticleId IdType="pubmed">24026711</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson, B. K. et al. Persistence of SARS-CoV2-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection. Front. Immunol.12, 746021. 10.3389/fimmu.2021.746021 (2022). 10.3389/fimmu.2021.746021</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746021</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietik&#xe4;inen, A. et al. Cerebrospinal fluid cytokines in CLD neuroborreliosis. J. Neuroinflamm.18, 273. 10.1186/s12974-016-0745-x (2016).10.1186/s12974-016-0745-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0745-x</ArticleId><ArticleId IdType="pmc">PMC5070144</ArticleId><ArticleId IdType="pubmed">27756335</ArticleId></ArticleIdList></Reference><Reference><Citation>Widhe, M. et al. Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during CLD borreliosis in humans: Association with clinical outcome. J. Infect. Dis.189, 1881&#x2013;1891. 10.1086/382893 (2004). 10.1086/382893</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/382893</ArticleId><ArticleId IdType="pubmed">15122525</ArticleId></ArticleIdList></Reference><Reference><Citation>Jutras, B. L. et al. Borreliaburgdorferi&#xa0;peptidoglycan is a persistent antigen in patients with CLD arthritis. Proc. Natl. Acad. Sci. U. S. A.116, 13498&#x2013;13507. 10.1073/pnas.1904170116 (2019). 10.1073/pnas.1904170116</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1904170116</ArticleId><ArticleId IdType="pmc">PMC6613144</ArticleId><ArticleId IdType="pubmed">31209025</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawasaki, Y., Zhang, L., Cheng, J. K. &amp; Ji, R. R. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J. Neurosci.28, 5189&#x2013;5194. 10.1523/JNEUROSCI.3338-07.2008 (2008). 10.1523/JNEUROSCI.3338-07.2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3338-07.2008</ArticleId><ArticleId IdType="pmc">PMC2408767</ArticleId><ArticleId IdType="pubmed">18480275</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, J. X. et al. Potential neuroimmune interaction in chronic pain: A review on immune cells in peripheral and central sensitization. Front. Pain Res.3, 946846. 10.3389/fpain.2022.946846 (2022).10.3389/fpain.2022.946846</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpain.2022.946846</ArticleId><ArticleId IdType="pmc">PMC9289261</ArticleId><ArticleId IdType="pubmed">35859655</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, T., Chen, X., Zhang, C., Zhang, Y. &amp; Yao, W. An update on reactive astrocytes in chronic pain. J. Neuroinflamm.16, 140. 10.1186/s12974-019-1524-2 (2019).10.1186/s12974-019-1524-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1524-2</ArticleId><ArticleId IdType="pmc">PMC6615111</ArticleId><ArticleId IdType="pubmed">31288837</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu, C. B., Blakely, R. D. &amp; Hewlett, W. A. The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology10, 2121&#x2013;2131. 10.1038/sj.npp.1301029 (2006).10.1038/sj.npp.1301029</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.npp.1301029</ArticleId><ArticleId IdType="pubmed">16452991</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong, A. C. et al. Serotonin reduction in post-acute sequelae of viral infection. Cell186(4851&#x2013;4867), e20. 10.1016/j.cell.2023.09.013 (2023).10.1016/j.cell.2023.09.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.09.013</ArticleId><ArticleId IdType="pmc">PMC11227373</ArticleId><ArticleId IdType="pubmed">37848036</ArticleId></ArticleIdList></Reference><Reference><Citation>Costanza, M. Type 2 Inflammatory responses in autoimmune demyelination of the central nervous system: Recent advances. J. Immunol. Res.8, 4204512. 10.1155/2019/4204512 (2019).10.1155/2019/4204512</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/4204512</ArticleId><ArticleId IdType="pmc">PMC6530110</ArticleId><ArticleId IdType="pubmed">31205957</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasudeva, K. et al. In vivo and systems biology studies implicate IL-18 as a central mediator in chronic pain. J. Neuroimmunol.283, 43&#x2013;49. 10.1016/j.jneuroim.2015.04.012 (2015). 10.1016/j.jneuroim.2015.04.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2015.04.012</ArticleId><ArticleId IdType="pmc">PMC4465386</ArticleId><ArticleId IdType="pubmed">26004155</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos, D. et al. TNF-alpha and Notch signaling regulates the expression of HOXB4 and GATA3 during early T lymphopoiesis. In Vitro Cell. Dev. Biol. Anim.52, 920&#x2013;934. 10.1007/s11626-016-0055-8 (2016). 10.1007/s11626-016-0055-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11626-016-0055-8</ArticleId><ArticleId IdType="pubmed">27251160</ArticleId></ArticleIdList></Reference><Reference><Citation>Celik, M. &#xd6;., Labuz, D., Keye, J., Glauben, R. &amp; Machelska, H. IL-4 induces M2 macrophages to produce sustained analgesia via opioids. JCI Insight5, e133093. 10.1172/jci.insight.133093 (2020). 10.1172/jci.insight.133093</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.133093</ArticleId><ArticleId IdType="pmc">PMC7101153</ArticleId><ArticleId IdType="pubmed">32102987</ArticleId></ArticleIdList></Reference><Reference><Citation>Kipnis, J., Gadani, S. &amp; Derecki, N. C. Pro-cognitive properties of T cells. Nat. Rev. Immunol.12, 663&#x2013;669. 10.1038/nri3280 (2012). 10.1038/nri3280</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3280</ArticleId><ArticleId IdType="pmc">PMC4032225</ArticleId><ArticleId IdType="pubmed">22903149</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>